IN BRIEF: Proteome Sciences reaches "sales milestone" from contract

Proteome Sciences PLC - drug development services provider - Achieves "cumulative sales ...

Alliance News 5 January, 2023 | 10:45AM
Email Form Facebook Twitter LinkedIn RSS

Proteome Sciences PLC - drug development services provider - Achieves "cumulative sales milestone" with life sciences company Thermo Fisher Scientific Inc. Says a payment of GBP870,000 has been received by the company and will be recognised in the 2022 financial year. Proteome Sciences has an exclusive licence and distributor agreement with Thermo Scientific.

Current stock price: 3.50 pence

12-month change: down 33%

By Sophie Rose; Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
Proteome Sciences PLC 3.90 GBX -2.50 -

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures